Does the Addition of an Oral β2 Agonist (Pirbuterol) to Long Term Oxygen Therapy Yield Further Benefit in Hypoxic Chronic Bronchitis and Emphysema?
Year: 1987
Type: article
Source: Clinical Science
DOI: 10.1042/cs072054pb
Authors: W Biernacki, KF Whyte, K Prince, W MacNee, DC Flenley
Institution: University of Edinburgh
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2921063703